Unlock stock picks and a broker-level newsfeed that powers Wall Street.
34.19
+1.05
+(3.17%)
At close: April 2 at 4:00:01 PM EDT
32.21
-1.98
(-5.79%)
Pre-Market: 8:26:45 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 18 | 18 | 25 | 21 |
| Avg. Estimate | -1.25 | -1.25 | -4.81 | -3.81 |
| Low Estimate | -1.74 | -1.78 | -6.91 | -7.69 |
| High Estimate | -0.74 | -0.86 | -2.91 | 3.95 |
| Year Ago EPS | -1.43 | -1.49 | -4.34 | -4.81 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 14 | 14 | 24 | 20 |
| Avg. Estimate | 6.46M | 9.3M | 61.85M | 224.96M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | 16.7M | 30.89M | 157M | 1.48B |
| Year Ago Sales | 504k | 517k | 37.31M | 61.85M |
| Sales Growth (year/est) | 1,182.18% | 1,698.99% | 65.75% | 263.72% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -1.46 | -1.43 | -1.4 | -1.19 |
| EPS Actual | -1.43 | -1.49 | -1.01 | -0.44 |
| Difference | 0.03 | -0.06 | 0.39 | 0.75 |
| Surprise % | 2.38% | -4.44% | 28.11% | 62.89% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -1.25 | -1.25 | -4.81 | -3.81 |
| 7 Days Ago | -1.28 | -1.28 | -4.89 | -3.96 |
| 30 Days Ago | -1.28 | -1.28 | -4.89 | -3.96 |
| 60 Days Ago | -1.4 | -1.39 | -5.11 | -3.1 |
| 90 Days Ago | -1.38 | -1.36 | -5.02 | -2.89 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 2 |
| Up Last 30 Days | 6 | 5 | 12 | 2 |
| Down Last 7 Days | -- | -- | 1 | 5 |
| Down Last 30 Days | 3 | 4 | 9 | 8 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CRSP | 12.49% | 15.80% | -10.84% | 20.82% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Reiterates | Cantor Fitzgerald: Neutral to Neutral | 2/19/2025 |
| Maintains | Citigroup: Buy to Buy | 2/18/2025 |
| Maintains | Morgan Stanley: Underweight to Underweight | 2/14/2025 |
| Upgrade | Evercore ISI Group: In-Line to Outperform | 2/14/2025 |
| Maintains | Goldman Sachs: Neutral to Neutral | 2/13/2025 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 2/13/2025 |
Related Tickers
NTLA Intellia Therapeutics, Inc.
7.30
+9.69%
BEAM Beam Therapeutics Inc.
18.48
+4.79%
RXRX Recursion Pharmaceuticals, Inc.
5.29
+3.83%
MRNA Moderna, Inc.
27.72
+2.06%
VRTX Vertex Pharmaceuticals Incorporated
483.49
-0.26%
BLUE bluebird bio, Inc.
5.03
-4.19%
EDIT Editas Medicine, Inc.
1.1800
+4.42%
SRPT Sarepta Therapeutics, Inc.
62.47
+0.90%
VKTX Viking Therapeutics, Inc.
25.68
+7.40%
PCVX Vaxcyte, Inc.
33.69
+4.53%